Observational Study
Copyright ©The Author(s) 2021.
World J Gastrointest Endosc. Sep 16, 2021; 13(9): 407-415
Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.407
Table 3 Clinical prognosis of ulcerative colitis with rectal sparing versus without rectal sparing (control)

Rectal sparing UC (n = 24)
Control (n = 72)
P value
Age35.8 ± 11.036.6 ± 10.6Matched
Sex (male:female)19:557:15Matched
Disease extent (E2/E3)8/1624/48Matched
Follow-up period (mo)103.4 ± 41.3109.4 ± 41.6 0.5
Clinical outcomes
Use of systemic corticosteroid0.77
3-yr cumulative rate 35.3%34.7%
5-yr cumulative rate46.0%41.8%
10-yr cumulative rate53.8%61.1%
Use of biologics4 (16.7%)10 (13.9%)0.74
Hospitalization4 (16.7%)16 (22.2%)0.77
Colectomy2 (8.3%)2 (2.8%)0.26